Home Cart Sign in  
Chemical Structure| 1661839-45-7 Chemical Structure| 1661839-45-7

Structure of CCT251545
CAS No.: 1661839-45-7

Chemical Structure| 1661839-45-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CCT251545 is an orally bioavailable and potent inhibitor of WNT signaling with IC50 value of 5 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CCT251545

CAS No. :1661839-45-7
Formula : C23H24ClN5O
M.W : 421.92
SMILES Code : O=C1NCCC12CCN(C3=C(Cl)C=NC=C3C4=CC=C(C5=CN(C)N=C5)C=C4)CC2
MDL No. :MFCD29472582
InChI Key :LBFYQISQYCGDDW-UHFFFAOYSA-N
Pubchem ID :77050682

Safety of CCT251545

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
CCT251545, an orally bioavailable and potent WNT signaling inhibitor, exhibits an IC50 of 5 nM in 7dF3 cells[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293 20 μM 24 hours Screening for WNT signaling pathway inhibitors, discovered CCT251545 PMC4767141
COLO205-F1756 clone 4 0.035 ± 0.003 μM Inhibition of WNT pathway activity PMC4767141
PA-1 0.007 μM Inhibition of WNT3a ligand-dependent reporter readout PMC4767141
SW480 0.190 ± 0.030 μM Inhibition of WNT pathway activity PMC4767141
LS174T 0.023 ± 0.011 μM Inhibition of WNT pathway activity PMC4767141

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse COLO205-F1756 clone 4 human tumor xenograft model Oral 70 mg/kg Twice daily for 8 days Inhibition of WNT signaling and evidence for tumor growth inhibition PMC4767141

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.37mL

0.47mL

0.24mL

11.85mL

2.37mL

1.19mL

23.70mL

4.74mL

2.37mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories